Genmab — December 2018
-
Man kan da bare kigge på PFS kurven. Så tror jeg patienterne er ligeglade med MRD ? https://ash.confex.com/ash/2018/webprogram/Paper120737.html
-
Torben Plesner på ASH https://twitter.com/michaelodwyermd/status/1069400104296079360?s=21
-
-
-
Bluebird/Celgene bb21217 BCMA CAR-T https://www.marketwatch.com/press-release/bluebird-bio-and-celgene-corporation-present-initial-data-from-ongoing-phase-1-clinical-study-of-next-generation-anti-bcma-car-t-cell-therapy-bb21217-in-patients-with-relapsedrefractory-multiple-myeloma-at-ash-annual-meeting-2018-12-02
-
God morgen.
-
Genopfriskning på R&D Update i dag. https://ir.genmab.com/news-releases/news-release-details/genmab-hold-rd-update-and-2018-ash-data-review-meeting-0
-
https://www.youtube.com/watch?v=iemqPGiyapY Promising Findings for Daratumumab Plus VRd in Multiple Myeloma
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind